

The APAC biopharmaceutical contract manufacturing market is at USD 1.38 billion in 2022 and is projected to grow at 2.16 billion in 2027 at a CAGR of 9.38%. Asia-Pacific is the fastest growing region due to low labour costs, regulatory relaxation, abundance availability of raw materials, infrastructure facility, rise in generic demands, increased production capabilities, the presence of a large number of domestic and international players and comparatively low investments required for the establishment of manufacturing facilities, as opposed to western countries. This new trend of outsourcing is resulting in many benefits to the CMOs in multiple Asian countries, such as Singapore, South Korea, India, and China. Many companies see growth opportunities in this sector.
The 2nd Biologics Contract Manufacturing Asia 2023 is a premium event that focuses exclusively on Contract Manufacturing in Asia-Pacific. The conference addresses the growing market of contract manufacturing, the predicted trends in the market, challenges faced by CMOs/ CDMOs, as well as the solutions and opportunities moving forward. We bring the entire eco-system together – from experts in the biologics manufacturing space, to academia and regulatory – to foster partnerships, share insights and stay on the cutting edge of new developments.
Catch the latest in Asia-Pacific's contract manufacturing sector. From current best practices to advancing towards SMART manufacturing, from recent most-exclusive case-studies to industry's key needs. All this and more under 1 roof!
Leadership Panel Discussion by APAC Leaders: Extensive Insights into the Biologics Contract Manufacturing Market in APAC region
Flexibility in Manufacturing and Analytics with Platform Technologies
Accelerate Manufacturing Processes to Reduce Cost and Expedite Timelines
SMART Manufacturing: Bioprocessing 4.0
Integration of Continuous Processes & Scale Up Strategies
Strategic Partnerships and Collaborations with CMO/CDMOs for Enhanced Productivity
GMP/cGMP Manufacturing Requirements and Processes
Biologics CMO/CDMO Case Studies from APAC
Access Pass - End User (CMOs Headquarter Located in ASIA)
- Limited Special SGD $1595 (until 26th May)
- Super Earlybird SGD $1795 (until 30th June)
- Earlybird SGD $1995 (until 4th August)
- Standard Price SGD $2195
Access Pass - Vendor/BD/MKT (CMOs Headquarter Located Outside of ASIA)
- Limited Special SGD $3295 (until 26th May)
- Super Earlybird SGD $3495 (until 30th June)
- Earlybird SGD $3695 (until 4th August)
- Standard Price SGD $3895
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.